MMP-12 Antibodies

Santa Cruz Biotechnology provides a broad selection of MMP-12 Antibodies for research focused on matrix metalloproteinase-12. MMP-12 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Matrix metalloproteinase-12 is a crucial enzyme involved in the degradation of extracellular matrix components, playing a significant role in tissue remodeling and inflammation. Its dysregulation has been implicated in various pathological conditions, including chronic obstructive pulmonary disease (COPD) and cancer metastasis. Understanding matrix metalloproteinase-12 function is essential for developing therapeutic strategies targeting these diseases. Research has shown that matrix metalloproteinase-12 expression levels can serve as important biomarkers in disease progression. Recent studies have highlighted the importance of matrix metalloproteinase-12 in immune cell recruitment and inflammatory responses. Matrix metalloproteinase-12 has emerged as a potential therapeutic target in multiple disease models. Santa Cruz Biotechnology monoclonal antibodies for matrix metalloproteinase-12 support researchers worldwide in advancing scientific understanding of disease mechanisms and potential treatments.